Design, Synthesis, and Biological Activity of Novel Dicoumarol Glucagon-like Peptide 1 Conjugates
- 13 December 2013
- journal article
- research article
- Published by American Chemical Society (ACS) in Journal of Medicinal Chemistry
- Vol. 56 (24) , 9955-9968
Abstract
Twelve novel dicoumarol glucagon-like peptide 1 (GLP-1) conjugates were designed, synthesized, and tested for biological activity. All derivatives retained receptor activation efficacy, and exhibited improved albumin affinity and in vitro stability in rat plasma. The in vivo elimination half-lives of 13c and 13l (22.07 and 18.78 h, respectively) were much longer than those of the GLP-1 receptor agonists exendin-4 (2.82 h) and liraglutide (12.53 h). The prolonged in vivo antidiabetic effects of 13c and 13l on db/db mice were confirmed by the hypoglycemic efficacy test and the multiple intraperitoneal glucose tolerance test. Importantly, a once daily administration of 13c to db/db mice for 7 weeks provided long-term beneficial effects by lowering glycated hemoglobin (HbA1c) levels to 5.05%, which was lower than with liraglutide treatment (5.41%). These results suggest that 13c is a promising long-lasting GLP-1 mimetic that may be suitable for clinical use following further research.Keywords
This publication has 46 references indexed in Scilit:
- Efficacy and Safety of Incretin Therapy in Type 2 DiabetesJAMA, 2007
- Direct Effects of Glucagon-Like Peptide-1 on Myocardial Contractility and Glucose Uptake in Normal and Postischemic Isolated Rat HeartsThe Journal of Pharmacology and Experimental Therapeutics, 2006
- The biology of incretin hormonesCell Metabolism, 2006
- Therapeutic Approaches to Preserve Islet Mass in Type 2 DiabetesAnnual Review of Medicine, 2006
- Glucagon-like peptide 1 receptor agonists and dipeptidyl peptidase IV inhibitors: new therapeutic agents for the treatment of type 2 diabetesCurrent Opinion in Endocrinology, Diabetes and Obesity, 2005
- Glucagon-like peptide 1(GLP-1) in biology and pathologyDiabetes/Metabolism Research and Reviews, 2005
- Global Prevalence of DiabetesDiabetes Care, 2004
- EASD News Section March 2003Diabetologia, 2003
- The role of impaired early insulin secretion in the pathogenesis of Type II diabetes mellitusDiabetologia, 2001
- Tissue and Plasma Concentrations of Amidated and Glycine-Extended Glucagon-Like Peptide I in HumansDiabetes, 1994